Home / Videos / Succeed with Sirion – Transduction Enhancer LentiBOOST®
Succeed with Sirion – Transduction Enhancer LentiBOOST®
videosSIRION Biotech GmbH
December 16th 2021
A study by Vania Lo Presti and her colleagues shows efficient gene modification of CB CD8+ T cells using LV to potentially generate off-the-shelf T cell therapy products for cancer treatment. SIRION’s LentiBOOST® was proven a non-toxic transduction enhancer of CB CD8+ T cells in this study published in the Molecular Therapy – Methods and Clinical Development journal: https://bit.ly/Sir78.
Succeed with Sirion
LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications
We would like to bring you similar content and keep you informed with updates from this supplier. By submitting this form you agree to receive these updates. We take your privacy seriously, you can unsubscribe at anytime by clicking on the unsubscribe link.
